课题基金 / 基金详情

Analysis of regulatory mechanism of hematopoiesis and exploration of the pathogenesis of hematopoietic neoplasms through comprehensive genetic analysis

Analysis of regulatory mechanism of hematopoiesis and exploration of the pathogenesis of hematopoietic neoplasms through comprehensive genetic analysis
综合遗传学分析造血调控机制及探索造血肿瘤发病机制
批准号:
17013022
负责人:
OGAWA Seishi
金额:
$40.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

OGAWA Seishi的其他基金

相似基金

相关文献

中文摘要
翻译
造血肿瘤是由基因突变引起的造血系统正常成分的失调引起的。事实上,许多被确认为造血肿瘤原因的基因变化涉及到那些与正常的造血调控有关的基因。在这项研究中,我们使用高密度SNP阵列对2000多种血液肿瘤进行了全面的遗传分析。我们确定了一些与造血肿瘤发病相关的基因改变,包括髓系肿瘤中c-CBL的功能获得突变和B系淋巴瘤中A20的失活突变,并对它们进行了功能分析。这些发现不仅有助于我们理解血液病的分子发病机制,而且有助于增加我们对正常造血调控机制的认识,以及开发针对这些肿瘤的新的诊断和治疗方法。
英文摘要
Hematopoietic neoplasms are caused by deregulation of normal components of the hematopoietic system by gene mutations. In fact, many of genetic changes identified as a cause of hematopoietic neoplasms involves those genes implicated in normal regulation of hematopoiesis. In this study, we performed comprehensive genetic analyses of more than 2,000 hematopoietic neoplasms using high-density SNP arrays. We identified a number of genetic alterations involved in the pathogenesis of hematopoietic neoplasms, including gain-of-function mutations of c-CBL in myeloid neoplasms and inactivation mutations of A20 in B-lineage lymphomas, followed by their functional analysis. These findings are thought to contribute not only to our understanding of molecular pathogenesis of hematopoietic cancers, but also to adding our knowledge on regulatory mechanisms of normal hematopoiesis, together with the development of novel diagnostics and therapeutics for these neoplasms.
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1349-7006.2010.01500.x
发表时间: 2010-05
期刊: Cancer Science
影响因子: 5.7
作者: [Motohisa Tada;F. Kanai;Yasuo Tanaka;M. Sanada;Y. Nannya;K. Tateishi;M. Ohta;Yoshinari Asaoka;Motoko Seto;F. Imazeki;H. Yoshida;S. Ogawa;O. Yokosuka;M. Omata]
通讯作者: Motohisa Tada;F. Kanai;Yasuo Tanaka;M. Sanada;Y. Nannya;K. Tateishi;M. Ohta;Yoshinari Asaoka;Motoko Seto;F. Imazeki;H. Yoshida;S. Ogawa;O. Yokosuka;M. Omata
SNP chip analysis of myelodysplastic syndromes disclosed High Frequency of uniparental disomy and a novel dominant mutation as the target of 11qUPD
骨髓增生异常综合征的 SNP 芯片分析揭示了高频率的单亲二体性和作为 11qUPD 目标的新型显性突变
DOI: --
发表时间:
期刊:
影响因子: --
作者: [Sanada M, Lee-Y., Shih L, Suzuki T, Yamamoto G, Nannya Y, Yanagimoto-Sakata M, Kato M, Kumano K, Kawamata N, Mori H, Kurokawa M, Chiba S, Omine M, Koeffler PH, S Ogawa]
通讯作者: S Ogawa
Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.
与骨髓肿瘤中 11q 单亲二体性相关的功能获得性 c-CBL 突变。
DOI: --
发表时间: 2010
期刊: Cell Cycle. 9
影响因子: --
作者: [Ogawa S, Sanada M, Shih LY, Suzuki T, Otsu M, Nakauchi H, Koeffler HP.]
通讯作者: Koeffler HP.
DOI: 10.1093/hmg/ddm205
发表时间: 2007-10-15
期刊: HUMAN MOLECULAR GENETICS
影响因子: 3.5
作者: [Nannya, Yasuhito, Taura, Kenjiro, Ogawa, Seishi]
通讯作者: Ogawa, Seishi
56
    Analysis of autoimmune mechanisms of myelodysplastic syndromes
    • 批准号:
      25670446
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      OGAWA Seishi
    • 依托单位:
    Identification of gene targets for molecular diagnosis and therapeutics in hematopoietic malignancies based on advanced genomics
    • 批准号:
      20390266
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2009
    • 负责人:
      OGAWA Seishi
    • 依托单位:
    Exploring leukemogenic mechanism using genomic analysis and mouse genetics.
    • 批准号:
      16390272
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2004
    • 负责人:
      OGAWA Seishi
    • 依托单位:
    GENOM IC ANALYSIS OF (1;7) TRANSLOCATION AND del(7q) IN MYELODYSPLASTIC SYNDROME
    • 批准号:
      14570962
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      OGAWA Seishi
    • 依托单位:
    海外基金